| ￥1200 | |
| A03105-50 | |
|
|
|
|
|
|
|
|
|
| Specificity | This product is specific to CD14 |
| Host Species | Rabbit |
| Immunogen | A synthesized peptide derived from human CD14 |
| Species Reactivity | Human |
| Conjugate | Unconjugated |
| Working concentrations for specific applications should be determined by the investigators. The appropriate concentrations may be affected by secondary antibody affinity, antigen concentration, the sensitivity of the method of detection, temperature, the length of the incubations, and other factors. The suitability of this antibody for applications other than those listed below has not been determined. The following concentration ranges are recommended starting points for this product. | |||||||||||
|
|||||||||||
| Form | Liquid |
| Storage Buffer | Supplied in 10mM phosphate buffered saline , pH 7.4, 150mM sodium chloride, 0.05% BSA, 0.02% sodium azide and 50% glycerol. |
| Storage Instructions | Store at -20°C. This product is stable for 1 year upon receipt, when handled and stored as instructed. |
| Purification | Affinity-chromatography |
| Isotype | Rabbit IgG |
| Clonality | Monoclonal |
Western blot analysis of CD14 expression in Human tonsil cell lysate. »
| Target Background | Coreceptor for bacterial lipopolysaccharide. In concert with LBP, binds to monomeric lipopolysaccharide and delivers it to the LY96/TLR4 complex, thereby mediating the innate immune response to bacterial lipopolysaccharide (LPS). |
| Synonyms | CD14; Monocyte differentiation antigen CD14; Myeloid cell specific leucine rich glycoprotein; |
For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.
